Evidence map›Paper›PMID 37702102›Full record

ArticleEpilepsia open2023

Abolition of seizures following Forel-H-tomy for drug-resistant epilepsy: A case report.

Shiro Horisawa, Satoru Miyao, Tomokatsu Hori, Kilsoo Kim, Takakazu Kawamata, Takaomi Taira

Open access · goldAbstract readCase Reports
In one paragraph

Article in Epilepsia open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Shiro HorisawaDepartment of Neurosurgery, Tokyo Women's Medical University, Shinjyuku, Japan.ORCID 0000-0002-3016-3244
Satoru MiyaoDepartment of Neurosurgery, TMG Asaka Medical Center, Asaka, Japan.
Tomokatsu HoriDepartment of Neurosurgery, Moriyama Memorial Hospital, Edogawa City, Japan.
Kilsoo KimDepartment of Neurosurgery, Tokyo Women's Medical University, Shinjyuku, Japan.
Takakazu KawamataDepartment of Neurosurgery, Tokyo Women's Medical University, Shinjyuku, Japan.
Takaomi TairaDepartment of Neurosurgery, Tokyo Women's Medical University, Shinjyuku, Japan.
Tokyo Women's Medical University · JPEdogawa Hospital · JPManipal University College Malaysia · MY

Funding

Japan Brain FoundationJSPS KAKENHI JP21K09113
6 · The paper itself

Abstract

A 62-year-old female experienced an extensive cerebral contusion in the left frontotemporal lobe due to an acute subdural hematoma at the age of 44 years. Six months after the injury, the patient developed epileptic seizures. The seizures were generalized with right cervical rotation and fencing posture. Despite prescriptions for four antiepileptic drugs, partial seizures occurred several times a month and focal to bilateral tonic-clonic seizures once every 2 months. Video-electroencephalography showed epileptic discharges in the left frontal lobe. The patient was subsequently referred to our department for palliative surgery. The patient underwent a left Forel-H-tomy. The prescription of antiepileptic drugs was not changed, and the patient was seizure free for 1 year. Forel-H-tomy, a surgical procedure for intractable epilepsy, was pioneered by Dennosuke Jinnai. Despite its previously reported remarkable efficacy, Forel-H-tomy has not been performed for several decades. Nevertheless, it remains a potential alternative treatment option for drug-resistant epilepsy.

Indexed as

Drug Resistant EpilepsyEpilepsyAdultAnticonvulsantsElectroencephalographyFemaleHumansMiddle AgedSeizuresAnticonvulsantsfields of Forelpallidothalamic tractradiofrequency ablation

Identifiers

PMID37702102
PMCPMC10690697
OpenAlexW4386704214

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.